Skip to main content

Day: September 21, 2021

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

Study demonstrating safety and tolerability of EXPAREL published in Journal of Clinical Anesthesia PARSIPPANY, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that full results of its Phase 3 PLAY study of EXPAREL® (bupivacaine liposome injectable suspension) administered via infiltration in pediatric patients undergoing spinal or cardiac surgeries have been published in Journal of Clinical Anesthesia. The study, which was designed to establish the safety and pharmacokinetics (PK) of EXPAREL in a pediatric population, found the PK profile was comparable across age groups and generally consistent with the profile in adult patients. No safety concerns were identified at a dose of 4 mg/kg. Key findings include:The safety of EXPAREL was comparable to bupivacaine and consistent across...

Continue reading

NFI schedules third quarter 2021 financial results release and conference call

WINNIPEG, Manitoba, Sept. 21, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that it intends to release its third quarter 2021 financial results on Wednesday, November 3, 2021 prior to market open. A conference call for analysts and interested listeners will be held on November 3, 2021, at 8:00 a.m. Eastern Time (ET). The call-in number for listeners is 661-567-1097 or 833-562-0121, passcode number 5466715. An accompanying results presentation will be available prior to the call at: www.nfigroup.com A live webcast of the call and presentation will also be available at: https://edge.media-server.com/mmc/p/7tqjksxw A replay of the call will be accessible from 11:00 a.m. ET on...

Continue reading

Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference

SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership Opportunities in Drug Delivery (PODD) Conference, October 28-29, 2021 in Boston. Progenity’s Vice President of Strategy and Operations, Chris Wahl, MD, MBA, will participate in the panel titled “Orally Ingestible Devices for Biologics Delivery” on Friday, October 29, at 9:35 a.m. ET. The panel discussion will be live-streamed and will be available on demand for three months following the conference to registered attendees. The session will explore oral delivery of biologics and the many technological approaches currently under investigation and showing promising results, including Progenity’s Oral Biotherapeutic Delivery System (OBDS),...

Continue reading

Luckin Coffee Enters into Binding Term Sheet to Settle U.S. Securities Class Action

BEIJING, Sept. 21, 2021 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (in Provisional Liquidation) (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has entered into a binding term sheet (the “Term Sheet”) with the Lead Plaintiffs in the provisionally certified class action In re Luckin Coffee Inc. Securities Litigation, Case No.1:20-cv-01293-JPC-JLC (SDNY) (the “Class Action”) to fully resolve all claims that have been or could be filed on behalf of a class of purchasers of the Company’s ADS between May 17, 2019 through July 15, 2020, inclusive, that has been certified for settlement purposes. Pursuant to the Term Sheet, the settlement is subject to entering into definitive documentation and obtaining approvals from the Cayman Court in the first instance (who has oversight of the provisional liquidation proceedings),...

Continue reading

Ribbon Cutting Ceremony Celebrates Opening of First Citrus Bank in the Heart of Downtown St. Petersburg

First Citrus Bank Celebrates National Small Business Week in St. Pete with Ribbon Cutting and Community-Driven CampaignFirst Citrus Bank St Pete Ribbon CuttingJack Barrett, President & CEO of First Citrus Bank along with Chris Steinocher, President & CEO of St Pete Chamber and other First Citrus Bank associates and board members cutting ribbon for new First Citrus Bank St Pete location.TAMPA, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) — First Citrus Bank, the St. Petersburg Chamber of Commerce, St. Pete Greenhouse, and the St. Petersburg Area Economic Development Corporation held a ribbon cutting ceremony on Thursday, September 16th, to officially celebrate the opening of the newest First Citrus Bank branch located in the heart of downtown St. Pete at 300 1st Ave S. National Small Business Week was an ideal...

Continue reading

AIM ImmunoTech Announces Positive Progress on Requested FDA Meeting for Proposed Ampligen Clinical Trial in Post-COVID-19 Cognitive Dysfunction

OCALA, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced positive progress with the company’s meeting request to the U.S. Food and Drug Administration (FDA) concerning a Phase 2 clinical study of Ampligen as an infusion therapy for Post-COVID-19 Cognitive Dysfunction (PCCD). The meeting request has been deemed sufficient for transfer to the FDA’s Division of Neurology by the FDA’s Covid Scientific Technical Triage Team. “We are pleased with this next step — the referral to the FDA’s Division of Neurology — as our focus is on the brain-related symptoms of Long COVID,” said AIM CEO Thomas K. Equels. The planned Phase 2, two-arm, randomized, double blind, placebo controlled, multicenter study is designed to evaluate the efficacy and safety of Ampligen in patients experiencing PCCD. Eighty...

Continue reading

Plato Gold Initiates a High-Resolution Airborne Magnetic and Radiometric Survey on the Good Hope Niobium Project

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC; Frankfurt: 4Y7 or WKN: A0M2QX) is pleased to announce it has signed a contract with Prospectair Geosurveys Inc. of Quebec to conduct a high-resolution Magnetic and Radiometric airborne geophysical survey on the Good Hope Niobium Project, located 60 km northwest of Marathon, Ontario. The survey is scheduled to begin at the end of September 2021 and be completed over a period of 1 to 3 days. A Media Snippet accompanying this announcement is available by clicking on the image or link below:Good Hope Niobium Property Location A Media Snippet accompanying this announcement is available by clicking on the image or link below:Geophysical Survey Plan (Prospectair Geosurveys Inc.) The planned airborne survey will better define the potential of the area surrounding...

Continue reading

VectivBio Announces Closing of Comet Therapeutics Acquisition

– Proprietary CoMET platform aims to treat severe rare Inherited Metabolic Diseases – BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the closing of its previously announced acquisition of Comet Therapeutics, Inc., a privately held company that has been developing drugs to address previously untreatable Inherited Metabolic Diseases (IMDs). Omar Khwaja, M.D., Ph.D., Chief Medical Officer of VectivBio, will present the CoMET platform at today’s VectivBio R&D Day, 10 a.m. – 12 p.m. EDT, that can be accessed by visiting the “Events & Presentations” section of VectivBio’s website. The CoMET small molecule platform aims to treat...

Continue reading

LGI Homes Opens New Section at Vacek Country Meadows in Richmond, Texas

Homebuilder offers move-in ready homes priced from the $240s in a highly desirable location in Fort Bend CountyThe Blanco plan at Vacek Country Meadows by LGI HomesLGI Homes at Vacek Country Meadows offers new, move-in ready homes and family-friendly amenities in Richmond, Texas. Pricing begins in the $240s.RICHMOND, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the company’s return to Vacek Country Meadows in Richmond, Texas, where the builder is constructing an additional 168 single-family homes priced from the $240s. Homeowners at Vacek Country Meadows enjoy move-in ready homes equipped with LGI’s CompleteHome™ package and a private neighborhood situated near I-69, TX-99 and the Sam Houston Tollway. “Vacek County Meadows offers a tremendous value to buyers in Fort Bend...

Continue reading

BioCryst to Present at 2021 Cantor Virtual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the 2021 Cantor Virtual Healthcare Conference on Tuesday, September 28, 2021 at 2:00 p.m. ET. Links to a live audio webcast and replay of this presentation may be accessed in the Investors section of BioCryst’s website at http://www.biocryst.com. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO® (berotralstat) is approved in the United States, the European Union, Japan, the United Kingdom and the United Arab Emirates. BioCryst has several ongoing development...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.